(Q35866381)

English

Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability

scientific article published on 23 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

0 references

multiple sclerosis

0 references

object named as

George A Jelinek

1

0 references

Tracey Joy Weiland

object named as

Tracey J Weiland

2

0 references

Claudia H Marck

object named as

Claudia H Marck

4

1 reference

ORCID Public Data File 2021

Emily J Hadgkiss

3

object named as

Emily J Hadgkiss

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Dania M van der Meer

6

object named as

Dania M van der Meer

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Naresh G Pereira

5

object named as

Naresh Pereira

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

23 April 2015

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Neurological Research

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

37

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

662-673

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

2014 multiple sclerosis therapeutic update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Improving quality of life in multiple sclerosis: an unmet need.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Disease-modifying agents in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Benefits of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Corticosteroids for the long-term treatment in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

14 November 2018

Validation of Italian multiple sclerosis quality of life 54 questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

27 July 2018

Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Mitoxantrone for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Does multiple sclerosis-associated disability differ between races?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Major depression and quality of life in individuals with multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507477

24 September 2018

The truly remarkable universality of half a standard deviation: confirmation through another look

1 reference

https://api.crossref.org/works/10.1179%2F1743132815Y.0000000036

21 January 2018

Changes in the ascertainment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1179%2F1743132815Y.0000000036

21 January 2018

Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand

1 reference

https://pubmed.ncbi.nlm.nih.gov/25905471

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25905471

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25905471

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease steps in multiple sclerosis: a simple approach to evaluate disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25905471

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1179/1743132815Y.0000000036

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35866381&oldid=1744533644"